BioNTech and InstaDeep announce AI Innovation Lab to develop novel immunotherapies
On Nov. 25, 2020, BioNTech and InstaDeep announced a multi-year strategic collaboration aimed at applying the latest advances…
On Nov. 25, 2020, BioNTech and InstaDeep announced a multi-year strategic collaboration aimed at applying the latest advances…
On Nov. 24, 2020, MediciNova announced that Good Manufacturing Practice (GMP)-based Master Virus Seed Stock (MVSS) production of…
On Nov. 20, 2020, the ‘European Food Safety Authority (EFSA) reported that within the past month more than…
On Nov. 20, 2020, Pfizer and BioNTech announced they submitted a request to the Food and Drug Administration…
On Nov. 18, 2020, Pfizer and BioNTech announced that, after conducting the final efficacy analysis in their ongoing…
On Nov. 13, 2020, BioNTech and Shanghai Fosun Pharmaceutica announced that the China National Medical Products Administration (hereinafter…
On Nov. 11, 2020, Pfizer and BioNTech announced that they had reached an agreement with the European Commission…
On Nov. 9, 2020, Pfizer and BioNTech announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 had demonstrated evidence…
On Nov. 2, 2020, Walgreens Boots Alliance (WBA) and McKesson announced the completion of their previously announced agreement…
On Oct. 26, 2020, Bayer announced the acquisition of Asklepios BioPharmaceutical, a US-headquartered biopharmaceutical company specialized in the…
On Oct. 20, 2020, the European Investment Bank (EIB) and Immunic announced the signing of a €24.5 million…
On Oct. 14, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from the Phase 1 portion of…
On Oct. 7, 2020, the Nobel Prize in Chemistry 2020 was awarded to Drs. Emmanuelle Charpentier and Jennifer…
On Oct. 7, 2020, Rentschler Biopharma announced an agreement to serve as CDMO partner for BioNTech. As an…
On Oct. 6, 2020, Pfizer and BioNTech announced the initiation of a rolling submission to the European Medicines…
On Oct. 5, 2021, the Nobel Prize in Chemistry 2020 was awarded to Benjamin List and David MacMillan…
On Sept. 30, 2020, researchers at the Karolinska Institutet in Sweden and the Max Planck Institute for Evolutionary…
On Sept. 30, 2020, the United Nations (UN) and its partners announced that nearly $1 billion in financing…
On Sept. 30, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their ongoing German Phase 1/2…
On Sept. 29, 2020, In a new Letter, published in PNAS, researchers at La Jolla Institute for Immunology…
On Sept. 24, 2020, an international research team led by the Max Planck Institute for Evolutionary Anthropology in…
On Sept. 17, 2020, BioNTech announced an agreement with Novartis to acquire their GMP certified manufacturing facility in…
On Sept. 15, 2020, BioNTech announced that it will receive a grant of up to 375 million Euro…
On Sept. 14, 2020, scientists at the Max Planck Institute for Infection Biology in Berlin and the Institut…
On Sept. 12, 2020, Pfizer and BioNTech announced that they had submitted an amended protocol to the FDA…
On Sept. 9, 2020, Pfizer and BioNTech announced preliminary preclinical data in mouse and non-human primate models from…
On Sept. 9, 2020, Pfizer and BioNTech announced that they had concluded exploratory talks with the European Commission…
On Sept. 8, 2020, the CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and…
On Sept. 7, 2020, Pfizer and BioNTech announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the…
On Sept. 1, 2020, Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara (sarilumab) at…